Total Clarity Wealth Management, Inc. Invitae Corp Transaction History

Total Clarity Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$14.7 - $28.67 $2,219 - $4,329	-151 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$24.31 - $33.6 $3,670 - $5,073	151 New	151 $4,000
Q2 2021 Jul 26, 2021	SELL	$26.09 - $40.4 $7,853 - $12,160	-301 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$33.06 - $56.93 $9,951 - $17,135	301 New	301 $12,000
Q1 2020 Apr 24, 2020	SELL	$7.64 - $27.5 $840 - $3,025	-110 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$15.02 - $20.57 $1,652 - $2,262	110 New	110 $2,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.